|
|
|
Volumn 3, Issue 4, 2005, Pages 312-
|
|
Medroxyprogesterone acetate better than venlafaxine at relieving hot flashes
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDEPRESSANT AGENT;
GESTAGEN;
MEDROXYPROGESTERONE;
RALOXIFENE;
TAMOXIFEN;
VENLAFAXINE;
ANOREXIA;
BREAST CANCER;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
DRUG TOLERABILITY;
FEMALE;
HOT FLUSH;
HUMAN;
MAJOR CLINICAL STUDY;
NAUSEA;
NOTE;
RANDOMIZED CONTROLLED TRIAL;
SINGLE DRUG DOSE;
SYMPTOMATOLOGY;
XEROSTOMIA;
BREAST NEOPLASMS;
CONTRACEPTIVE AGENTS, FEMALE;
CYCLOHEXANOLS;
FEMALE;
HOT FLASHES;
HUMANS;
MEDROXYPROGESTERONE 17-ACETATE;
RANDOMIZED CONTROLLED TRIALS;
SEROTONIN UPTAKE INHIBITORS;
|
|
EID: 23844490899
PISSN: 15446794
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|